Merck to buy Acceleron for about $11.5 billion in rare disease drugs push

September 30, 2021

(Reuters) – Merck & Co will buy drugmaker Acceleron Pharma Inc for about $11.5 billion, the companies said on Thursday, as the U.S. pharmaceutical giant looks to beef up its portfolio with drugs for rare diseases.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi and Sriraj kalluvila)

Source Link Merck to buy Acceleron for about $11.5 billion in rare disease drugs push